We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
3 watching
Current Price
$27.52
$0.45
(1.66%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
1,506.76M
52-Week High
66.45
52-Week Low
13.15
Average Volume
0.55M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,506.76M
52-Week High66.45
52-Week Low13.15
Average Volume0.55M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body s own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
30days ago
Kymera Therapeutics, Inc. (NASDAQ:KYMR Get Rating) major shareholder Venture Fund X. L.P. Atlas sold 96,581 shares of the firms stock in a transaction dated Wednesday, November 2nd. The stock was sold at an average price of $30.02, for a total transaction of $2,899,361.62. Following ...
Ticker Report
30days ago
Kymera Therapeutics, Inc. (NASDAQ:KYMR Get Rating) Director Bruce Booth sold 123,619 shares of the stock in a transaction dated Wednesday, November 2nd. The shares were sold at an average price of $30.02, for a total transaction of $3,711,042.38. Following the completion of the sale, the ...
TheStreet.com - Investing
3 months ago
In drug development, cash is king, especially during a market correction.In drug development, cash is king, especially during a market correction.If you think tech stocks have it rough right now, sneak a peek at biotech stocks. The sector is in the midst of its most severe correction ever. ...
Globe Newswire
3 months ago
WATERTOWN, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, announced that Nello Mainolfi, PhD, Co-Founder, President and ...
Globe Newswire
3 months ago
WATERTOWN, Mass., Aug. 19, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, has entered into a securities purchase agreement with certain ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$27.52
$0.45
(1.66%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00